NHS England removes Palantir list after 29 report limited use
NHS England removed a list saying 137 trusts benefited from Palantir’s AI platform after 29 reported limited or no use, reopening scrutiny of a £330m contract.
Topic
Topic
NHS England removed a list saying 137 trusts benefited from Palantir’s AI platform after 29 reported limited or no use, reopening scrutiny of a £330m contract.
Palantir CEO Alex Karp calls all products “essentially progressive” and says he has always been a Democrat, one week after the 20…
Palantir's Q3 revenue rose 96% to $2.31 billion and U.S. commercial revenue overtook government sales for the first time, yet PLT…
PLTR jumped 5.5% to $169.20 Monday and 82% of $39.3M in options premium went to calls. The Nov 3 gap at $176.54-$178.13 is the ne…
PLTR fell 10.3% before its November 2 report. Benchmarking the decline against SMH, QQQ and SPY shows why sector moves can distor…
WhatsApp messages show Palantir urged a UK health minister to open GP records to its software, despite a pledge that GP data woul…
Riste Gramatikov’s study of Palantir shows how embedded engineers can turn customer-specific deployments into reusable software a…
Palantir booked its first $2 billion revenue quarter and a 53% FCF margin, yet shares fell 3% as US commercial deal growth slowed…
Palantir's revenue topped $2 billion for the first time, but slowing bookings growth sent shares down 8% to $164.05 in premarket…
Palantir beat estimates with $2.31B revenue, up 96%, but enterprise contract value fell 31% from the prior quarter, hinting at sl…
Palantir grew revenue 96% to $2.3 billion in Q3, raised full-year guidance to $8.53 billion, and saw US commercial sales top gove…